Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Silver oxide nanoparticles are nanoscale particles composed of silver in its oxidized form (commonly Ag2O or AgO), typically ranging from 1 to 100 nanometers in size. They exhibit unique physicochemical properties distinct from bulk silver and other forms of silver compounds. Silver oxide nanoparticles are primarily investigated for their potent antimicrobial activity, including antibacterial, antifungal, and antiviral effects. Their mechanism of action involves the generation of reactive oxygen species (ROS), disruption of microbial cell membranes, and interference with essential proteins via interaction with thiol groups[8]. These properties make them promising candidates for use as pharmaceutical antibacterials, disinfectants, wound dressings, coatings for medical devices, and potential agents in drug delivery systems[2][8]. Research also explores their applications in cancer therapy due to cytotoxic effects on tumor cells while minimizing toxicity to healthy tissue[4][5]. The synthesis methods include chemical reduction and green synthesis using biological agents such as plant extracts or microbes for enhanced biocompatibility[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on silver oxide nanoparticles.